Rapidly evolving research and regulatory markets are focused on BP from both an efficacy and a safety endpoint. Bioclinica is a leader in the implementation and standardization of blood pressure monitoring within the clinical research and development arena. Bioclinica is an international service provider of blood pressure solutions, including Ambulatory Blood Pressure Monitoring, 24 hour pulse wave assessment and automated home and office BP solutions to fit the specific needs of a clinical trial design. Both the home and office BP monitoring include remote data telemonitoring either directly from the patient’s home or clinic to a centralized study data base. Bioclinica can support a series of options to meet the needs of a study from early clinical development through late stage clinical trials and provide a unique blood pressure monitoring solution for you.
Ambulatory Blood Pressure Monitoring (ABPM) - From Efficacy to Safety
Bioclinica began integrating ABPM technology and services within the anti-hypertensive research indication over 25 years ago. Besides being actively used and regarded as a key diagnostic technology within hypertension research, ABPM data are now included in a number of regulatory submissions for novel drugs, serve as a surrogate endpoint to describe the changes in blood pressure over 24 hour time periods (circadian patterns), and are increasingly considered for determining new drug safety during regulatory review.
Bioclinica's full range of ABPM services include:
Design and review of protocols for optimal ABPM data collection
Case report form (CRF) recommendations
Study equipment, validation and hands-on site training
Web-based ABPM platform optimized for standardized data collection, security and study site integration
Real-time, onsite, quality control checks
Flexibility with ABPM technology to meet the study requirements, therapeutic indication and population
Cardiac safety BP threshold notification based on study criteria
Advanced statistical reporting on ABPM data
As leaders in the conduct of trials with blood pressure endpoints, Bioclinica maintains a leadership role in shaping regulatory trends through active participation with the Metrics Champions Consortium (MCC) and the Cardiac Safety Research Consortium (CSRC). With unparalleled experience in the management of protocols using ABPM technology, Bioclinica has provided comprehensive ABPM services for pharmaceutical, biotech, and government sponsors. Our ABPM and BP data have been used in NDA submissions as part of the drug approval process. Bioclinica is an international provider of ABPM with more than 36 years of cumulative research experience. We have supported >300 protocols and 300,000 ABPM records across the globe.
Automated Blood Pressure
Automated blood pressure (BP) measurement is increasingly viewed as a preferred alternative to traditional methods of BP measurement in clinical trials. Bioclinica has proven experience integrating automated BP in clinical trials for both office and home environments.
Benefits of Automated office BP monitoring:
calibration and standardization of equipment across study sites
removal of variability resulting from human/auscultatory bias
Benefits of Automated home BP monitoring:
Capture of BP data in a comfortable environment
Elimination of the white-coat effect
Elimination of transcription errors (when implemented as a remote telemedicine solution)
Early identification of trends in BP responses
Early endpoint identification (adaptive clinical trial design)
Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.